RTOG-0415
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-Risk Prostate Cancer
Principal Investigator
W. Robert Lee
Status
Terminated
Closed to Accrual & Treatment
March 17, 2010
Complete
April 4, 2016
Terminated
December 22, 2022
Disease Site
Genitourinary [GU] Prostate
Phase
III
Developmental Therapeutics
No
Patient Population
–
Target Accrual
1067
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
